News & Events
Oxygen Biotherapeutics Receives Favorable NASDAQ Listing Decision
MORRISVILLE, N.C.--(BUSINESS WIRE)--May. 16, 2013-- Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), today announced that the NASDAQ Listing Qualifications Panel (the “Panel”) has granted the Company’s request for continued listing on The NASDAQ Capital Market pursuant to an extension through June 3, 2013 to evidence compliance with the minimum $1.00 bid price requirement and through July 31, 2013 to evidence compliance with the minimum $2.5 million stockholders’ equity requirement for continued listing on The NASDAQ Capital Market. more..
Quick Links
The mission of Oxygen Biotherapeutics is to research, develop and market oxygen related topical and intravenous products based on our perfluorocarbon technology. Our dedicated team is driven by the promise of utilizing perfluorocarbons for saving lives, maintaining health and improving quality of life through improved oxygen delivery to tissues and organs.